IRIS
TRIFILETTI, Aldo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 799
EU - Europa 627
AS - Asia 160
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.588
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 798
IE - Irlanda 179
SE - Svezia 175
CN - Cina 131
UA - Ucraina 81
DE - Germania 78
FI - Finlandia 30
GB - Regno Unito 26
IT - Italia 25
BE - Belgio 17
SG - Singapore 16
CZ - Repubblica Ceca 10
IN - India 8
IR - Iran 4
FR - Francia 2
RU - Federazione Russa 2
BG - Bulgaria 1
CA - Canada 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
Totale 1.588
Salva come PNG Salva come JPEG
Città #
Chandler 183
Dublin 179
Jacksonville 158
Nyköping 103
Beijing 57
Ann Arbor 54
Ashburn 45
Cambridge 27
Medford 27
Princeton 27
Des Moines 25
Dearborn 21
Boardman 19
Bremen 19
Brussels 16
Lancaster 13
San Mateo 13
New York 12
Jinan 11
Brno 10
Singapore 9
Woodbridge 9
Tianjin 8
Haikou 7
Hangzhou 7
Nanjing 7
Munich 6
Shenyang 6
Leawood 5
Augusta 4
Guangzhou 4
Wilmington 4
Changsha 3
Clearwater 3
Helsinki 3
Jiaxing 3
Messina 3
Mumbai 3
Pune 3
Ardabil 2
Hebei 2
Houston 2
Los Angeles 2
Monmouth Junction 2
Nanchang 2
Ningbo 2
Sabz 2
San Benedetto del Tronto 2
Strasbourg 2
Taiyuan 2
Turin 2
Catania 1
Changle 1
Cupertino 1
Fuzhou 1
Hyderabad 1
Mountain View 1
Norwalk 1
Novokuznetsk 1
Phoenix 1
Puxian 1
Seattle 1
Taizhou 1
Vancouver 1
Washington 1
Zhengzhou 1
Totale 1.155
Salva come PNG Salva come JPEG
Nome #
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 85
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 82
null 78
Hemostatic changes in vasculitides. 74
Hemostatic disorders associated with arterial hypertension and peripheral arterial disease 73
Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease 71
Aspetti emoreologici ed emocoagulativi in corso di trattamento con buflomedil cloridrato 71
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 68
DOES ANTIYPERTENSIVE THERAPY REDUCE THE INCREASED INDEXES OF THROMBIN ACTIVATION IN PATIENTS WITH UNCONTROLLED ELEVATED BLOOD PRESSURE ? 66
Evaluation of haemostatic Parameters and Circadian Variations of the haemostatic System in Patients with systemic Sclerosis and Raynaud's Phenomenon 63
HEMOSTATIC DISORDERS IN DIFFERENT STAGES OF PERIPHERAL VASCULAR DISEASE 62
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 58
Hemostatic effects of diets containing olive oil or soy oil in hypertensive patients 58
HAEMOSTASIS IN SUBJECTS WITH FAMILY HISTORY OF TYPE 2 DIABETES AND HYPERTENSION 54
Study of Trombinic Activation Indexes, in Patients with lower Limb critic Ischaemia, before and after prostaglandinic E1 therapy 54
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 54
CORRELATION BETWEEN FAMILY HISTORY OF HYPERTENSION AND HAEMOSTATIC DISORDERS 52
HAEMOSTATIC EFFECTS OF CHOLESTEROL-LOWERING THERAPY WITH ATORVASTATIN 51
Efficacy evaluation of Prostaglandin E1 against placebo in Patients with progressive systemic sclerosis and significant Raynaud's Phenomenon 50
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 50
Increased indexes of thrombin activation in advanced stages of hypertension 50
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 50
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 49
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 47
Proprietà antiossidanti dell'olio di oliva 42
Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer 41
No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide 37
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 13
Totale 1.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020212 0 21 2 21 1 18 32 28 3 51 33 2
2020/2021193 26 2 44 7 4 23 3 22 0 17 38 7
2021/2022256 4 65 0 11 5 0 18 8 10 46 29 60
2022/2023624 46 71 29 57 60 59 7 47 221 3 11 13
2023/2024121 10 22 7 18 3 23 0 25 0 1 0 12
2024/202529 23 6 0 0 0 0 0 0 0 0 0 0
Totale 1.603